SYS-CON MEDIA Authors: Doug Masi, Mat Mathews, Newswire, David Smith, Tim Crawford

News Feed Item

Proception Medical, LLC. partners with Private Equity Fund to Evaluate Orthopaedic and Other Medical Device Investment Opportunities

LITTLE SILVER, N.J., March 5, 2014 /PRNewswire/ -- Proception Medical, LLC., a medical device incubator which in-licenses commercially viable inventions from surgeon inventors and develops them with the goal of exiting to an appropriate strategic partner,  has partnered with a private equity fund to seek and evaluate private investment and buy-out opportunities in the orthopaedic and medical device industries. 

Members of Proception Medical will be attending the Annual American Academy of Orthopaedic Surgeon Meeting in New Orleans next week to investigate investment and new product opportunities.

Proception Medical bridges the gap between surgeon inventor and strategic exits by taking the device through the development, regulatory approvals and limited launch process.  The partnership with the private equity firm allows Proception Medical to create similar value for companies needing investment or buy-out capital to achieve the next stage of growth, as they do for the surgeon inventor.   

The fund is looking at investment opportunities into revenue positive companies with sales up to $25M as well as product divestitures.

About Proception Medical, LLC. Proception Medical, LLC. has a singular mission: value creation.   As a medical device incubator, their goal is to in-license commercially viable inventions, develop them with a team of talented engineers, obtain the necessary commercialization approvals, then take them through a rigorous beta and limited launch with world class surgical partners. Their end goal is to then exit a clean, proven product, quickly, to an appropriate strategic partner. Contact: email: [email protected] phone: 732.882.6633, website:

SOURCE Proception Medical, LLC.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.